Adverse Drug Event-based Stratification of Tumor Mutations: A Case Study of Breast Cancer Patients Receiving Aromatase Inhibitors
Guoqian Jiang$lastName
You must log in to view this content. All contents are accessible to AMIA members and meeting attendees. If you are interested in purchasing proceedings, please contact us at mail@amia.org